Tolcapone
SIGMA/SML0150 - ≥98% (HPLC)
Synonym: 3,4-Dihydroxy-4′-methyl-5-nitrobenzophenone; Ro 40-7592
CAS Number: 134308-13-7
Empirical Formula (Hill Notation): C14H11NO5
Molecular Weight: 273.24
MDL Number: MFCD00866569
Linear Formula: C14H11NO5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow |
| form | powder |
| InChI | 1S/C14H11NO5/c1-8-2-4-9(5 |
| InChI key | MIQPIUSUKVNLNT-UHFFFAOYSA |
| originator | Roche |
| Quality Level | 100 ![]() |
| SMILES string | Cc1ccc(cc1)C(=O)c2cc(O)c( |
| solubility | DMSO: ≥15 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Application: | Tolcapone may be used in COMT-mediated cell signaling studies. Tolcapone has been used in methyltransferase assay in human embryonic kidney 293 cells. |
| Biochem/physiol Actions: | Inhibition of catechol-O-methyltransfer |
| Biochem/physiol Actions: | Orally active catechol-O-methyltransfer |
| Biochem/physiol Actions: | Tolcapone is an orally active catechol-O-methyltransfer |
| Features and Benefits: | This compound was developed by Roche . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS09 |
| Signal word | Warning |
| Hazard statements | H400 |
| Precautionary statements | P273 |
| Hazard Codes | N |
| Risk Statements | 50 |
| Safety Statements | 61 |
| RIDADR | UN 3077 9 / PGIII |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


